Question 1

What is the catalog number for JNJ-37822681?

Accepted Answer

The catalog number for JNJ-37822681 is M27891.

Question 2

What sizes are available for JNJ-37822681?

Accepted Answer

JNJ-37822681 is available in the following size(s): 1 g, 100 mg, 500 mg, 2 mg, 5 mg, 10 mg, 25 mg.

Question 3

How many pack sizes does JNJ-37822681 come in?

Accepted Answer

JNJ-37822681 is available in 7 different pack sizes.

Question 4

Is JNJ-37822681 in stock?

Accepted Answer

JNJ-37822681 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is JNJ-37822681 used for?

Accepted Answer

JNJ-37822681 is a novel, highly selective dopamine D₂ receptor antagonist characterized by a rapid dissociation rate from the dopamine D₂ receptor.

Question 6

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

Question 7

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Question 8

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

JNJ-37822681

Product Specifications

CAS Number

Stability

Purity

Weight

Molecular Formula

Notes

Receptor

Available Sizes

Frequently Asked Questions

Explore Other Products

TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor) (VEGI/2052R), CF647 conjugate, 0.1mg/mL

(24S)-Secalciferol

Recombinant Human Lumican/LUM Protein (His Tag)

Recombinant Human Lumican/LUM Protein (His Tag)

Norethynodrel (>90%)

Recombinant TAK1 Antibody